Some Anemia Treatment Agents Increase Risk Of Blood Clots And Death In Cancer Patients
Mar 15th 2008Drug InformationBlood
Using erythropoiesis-stimulating agents (ESAs) in thetreatment of anemia increases the risk of venous thromboembolism (VTE)and death among cancer patients, according to an article in theFebruary 27, 2008 issue of JAMA.ESAs are a class of drugs that promote red blood cell production in thebody. The ESAs erythropoietin and darbepoetin are commonlyused in patients with cancer to treat anemia.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
